Mouse tumour models have suggested that central memory (Tcm) phenotype CD8+ T cells or T memory stem cells (Tscm) that possess potent expansion potential, but little inherent cytotoxic activity [1], are most effective for immunotherapy in this setting [2,3]. Here, CD8A is linked to neoplasm.